Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?

Kamp, Timothy J; Hamdan, Mohamed H; January, Craig T

Kamp, Timothy J; Hamdan, Mohamed H; January, Craig T.

Kamp TJ; Division of Cardiovascular Medicine Department of Medicine University of Wisconsin-Madison Madison WI.
Hamdan MH; Division of Cardiovascular Medicine Department of Medicine University of Wisconsin-Madison Madison WI.
January CT; Division of Cardiovascular Medicine Department of Medicine University of Wisconsin-Madison Madison WI.

J Am Heart Assoc ; 9(12): e016887, 2020 06 16.

Article in English | MEDLINE | ID: covidwho-401222

Subject(s)

Betacoronavirus; Chloroquine/adverse effects; Coronavirus Infections/drug therapy; Heart Diseases/chemically induced; Hydroxychloroquine/adverse effects; Pandemics; Pneumonia, Viral/drug therapy; COVID-19; Cardiotoxicity; Chloroquine/therapeutic use; Coronavirus Infections/epidemiology; Global Health; Heart Diseases/epidemiology; Humans; Hydroxychloroquine/therapeutic use; Incidence; Pneumonia, Viral/epidemiology; SARS-CoV-2

Keywords

cardiotoxicity; drug therapy; long QT syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Chloroquine / Coronavirus Infections / Pandemics / Betacoronavirus / Heart Diseases / Hydroxychloroquine Type of study: Observational study Limits: Humans Language: English Journal: J Am Heart Assoc Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google